Herpes simplex virus type 1 establishes latent infection in trigeminal ganglia of mice infected via the eye. A family of three collinear viral transcripts (LATs), 2.0, 1.5, and 1.45 kb, is present in latently infected ganglia. To characterize these LATs, XgtlO cDNA libraries were constructed with RNAs isolated from the trigeminal ganglia of latently infected mice. A series of recombinant bacteriophage were isolated containing cDNA inserts covering 1.7 kb of the 2.0-kb LAT. Splice junctions of the smaller LATs and the 3' end of the 2.0-kb LAT were identified by sequence analysis of RNA polymerase chain reaction products. No splice was detected in the 2.0-kb LAT. The 3' end of the 2.0-kb LAT in vivo is upstream of a consensus splice acceptor site, which does not support the hypotheses that the 2.0-kb LAT is an intron. However, the data are consistent with the possibility of a short leader sequence or multiple LAT transcription start sites. To generate the smaller 1.5-and 1.45-kb LATs, there is a 559-nucleotide intron spliced from the 2.0-kb LAT in strain F and a 556-nucleotide intron in strain 17+. The nucleotide sequences at the 5' and 3' ends of these introns are characteristic of spliced transcripts from eukaryotic protein-encoding genes, with one significant difference; i.e., the 5' end of the LAT intron is GC instead of the consensus sequence GT. This splice donor sequence is conserved in herpes simplex virus type 1 strains F, 17+, and KOS. Processing of the 2.0-kb LAT to form the spliced LATs preserves two open reading frames (ORFs) at the 3' end of the LATs; no new ORFs are created. Splicing of the LATs positions a 276-nucleotide leader sequence close to these ORFs and removes an intron that inhibits their translation in vitro. The novel 5' structure of the intron within the 2.0-kb LAT may be part of a control mechanism for transcription processing that results in splicing of the LATs only in sensory neurons during latent infection and reactivation but not during the viral replication cycle.
Herpes simplex virus type 1 establishes latent infection in trigeminal ganglia of mice infected via the eye. A family of three collinear viral transcripts (LATs), 2.0, 1.5, and 1.45 kb, is present in latently infected ganglia. To characterize these LATs, XgtlO cDNA libraries were constructed with RNAs isolated from the trigeminal ganglia of latently infected mice. A series of recombinant bacteriophage were isolated containing cDNA inserts covering 1.7 kb of the 2.0-kb LAT. Splice junctions of the smaller LATs and the 3' end of the 2.0-kb LAT were identified by sequence analysis of RNA polymerase chain reaction products. No splice was detected in the 2.0-kb LAT. The 3' end of the 2.0-kb LAT in vivo is upstream of a consensus splice acceptor site, which does not support the hypotheses that the 2.0-kb LAT is an intron. However, the data are consistent with the possibility of a short leader sequence or multiple LAT transcription start sites. To generate the smaller 1.5-and 1.45-kb LATs, there is a 559-nucleotide intron spliced from the 2.0-kb LAT in strain F and a 556-nucleotide intron in strain 17+. The nucleotide sequences at the 5' and 3' ends of these introns are characteristic of spliced transcripts from eukaryotic protein-encoding genes, with one significant difference; i.e., the 5' end of the LAT intron is GC instead of the consensus sequence GT. This splice donor sequence is conserved in herpes simplex virus type 1 strains F, 17+, and KOS. Processing of the 2.0-kb LAT to form the spliced LATs preserves two open reading frames (ORFs) at the 3' end of the LATs; no new ORFs are created. Splicing of the LATs positions a 276-nucleotide leader sequence close to these ORFs and removes an intron that inhibits their translation in vitro. The novel 5' structure of the intron within the 2.0-kb LAT may be part of a control mechanism for transcription processing that results in splicing of the LATs only in sensory neurons during latent infection and reactivation but not during the viral replication cycle.
Latent herpes simplex virus type 1 (HSV-1) resides within neurons of sensory ganglia (8, 34) . Reactivation of latent HSV-1 to produce recurrent disease is common (39) and can be life threatening in immunosuppressed individuals. Viral transcripts have been detected by in situ hybridization during HSV-1 latency in the central and peripheral nervous systems of mice (10, 11, 17, 36, 45, 56, 58) and in human sensory ganglia (9, 18, 54, 55) . Within the region positive by in situ hybridization, three latency-associated transcripts (LATs), 2.0, 1.5, and 1.45 kb, have been detected by Northern (RNA) blot analysis (45, 49, 56, 59) . The LATs are encoded in the internal long repeat region, partially overlap the 3' terminus of the ICP0 gene, and are transcribed from the DNA strand complementary to that which encodes ICP0 mRNA (45, 49, 56) . Analysis of HSV-1 LAT promoter deletion mutants in animal models demonstrates that the LATs are not required for establishment or maintenance of latent infection (23, 30, 53) but that the LATs may augment the reactivation process (20, 30, 53) . Whether the action of the LATs is mediated by a protein product is unknown.
The structure and regulation of the LAT transcription unit are complex and distinct from those of other HSV-1 genes. The LAT promoter is located almost 700 nucleotides upstream of the 5' termini of the LATs (2, 13, 53, 67, 68) . The 2.0-kb LAT has been detected during HSV-1 replication in tissue culture cells (28, 49, 51, 54, 60) . The smaller LATs are spliced (60, 63) but have been detected only during latent * Corresponding author.
infection (50, 51) . During latency, the LATs are expressed in the absence of other viral RNAs, a characteristic of ot genes, yet in HSV-1-infected cells LAT expression is dependent upon both viral protein and DNA synthesis, a characteristic of y genes (51) . The mechanism(s) that controls the transcription and processing of the LATs during latent infection and the consequence(s) of splicing for LAT function are not known.
In the current work, the HSV-1 LATs were characterized by a combination of cDNA and RNA polymerase chain reaction (PCR) cloning. No splice was detected in the 2.0-kb LAT. A 559-nucleotide intron in strain F (556 nucleotides in 17+) is spliced from the 2.0-kb LAT to produce at least one of the smaller LATs. The 5' end of this intron has the novel sequence GC instead of GT. The other nucleotides surrounding the 5' and 3' intron termini are consistent with consensus splice junctions of eukaryotic protein-encoding genes (38) . The LAT splicing positions a 276-nucleotide leader sequence near the AUG of two potential open reading frames (ORFs), ORF1 and ORF2 ( Fig. 1; 64 ), which permits their translation in in vitro systems. It is proposed that a neuron-specific splicing factor(s) plays an essential role in the regulation of LAT processing.
MATERIALS AND METHODS
Cell culture and HSV-1 growth and titration. Subconfluent monolayers of CV-1 cells grown in Eagle's minimum essential medium supplemented with 5% fetal calf serum at 37°C with 5% CO2 were infected with HSV-1 strain F (from B. (42) . The approximate locations of ICP0, ICP27 (7, 31, 44, 62) , UL55, and UL56 mRNAs (51) are marked by arrows that indicate the direction of transcription. The shaded area between the PstI and MluI restriction sites hybridized by Northern blot analysis to three overlapping HSV-1 LATs, which are represented by a single arrow (49) . The hatched region is the boundary between the unique long region and the long internal repeat (31, 41) Roizman, University of Chicago) at 1 PFU per cell, and virus was concentrated from the medium as previously described (10, 11) . Stocks of HSV-1 strain 17+ (from J. Subak-Sharpe, University of Glasgow) were produced in BHK cells. The titers of virus stocks were determined on CV-1 and BHK cells.
Infection of mice and explant reactivation. Following corneal scarification, 4-to 6-week-old female BALB/c mice were infected with approximately 106 to 107 PFU of HSV-1 per eye (11, 52, 58) . At a minimum of 4 weeks after infection, latently infected mice were sacrificed by cervical dislocation and trigeminal ganglia were dissected and processed for RNA isolation or incubated with monolayers of CV-1 cells to confirm the presence of latent virus by reactivation.
RNA extraction, agarose gel electrophoresis, Northern blot transfer, and hybridization. Trigeminal ganglia were homogenized in 4 M guanidinium thiocyanate-0.5% sodium-Nlauroylsarcosine-100 mM ,-mercaptoethanol-25 mM sodium citrate-0.1% Antifoam A (Sigma), pH 7.0 (6), and total RNA was isolated as previously described (49) . RNA was denatured with glyoxal, electrophoresed in 1.2% agarose gels, and capillary blotted to Gene Screen Plus (Dupont), as previously described (49 (22) . In brief, approximately 3 x 104 PFU of recombinant phage were plated per 150-mm-diameter dish with top agar on BNN102, and nitrocellulose filter plaque replicas were prepared and hybridized with an HSV-1 BamHI-B probe. Since the phage density was too great to pick individual plaques, agar plugs were removed from regions of positive hybridization, phage were eluted into 1 ml of 10 mM Tris (pH 7.5)-10 mM MgCI2-0.1 mM disodium EDTA plus 2 drops of chloroform, the titers of the eluted recombinant phage were determined by plaque assay, and approximately 100 plaques were plated on a lawn of BNN102 on 100-mm-diameter dishes. Replica nitrocellulose filters were prepared and hybridized to BamHI-B as described above. Individual positive plaques were picked with a Pasteur pipet and placed into 1 ml of elution buffer. Phage DNA was prepared from liquid lysates by digestion with RNase A and proteinase K, phenol-chloroform extraction, and ethanol precipitation. Phage DNA was restricted with EcoRI and subcloned into M13. M13 clones containing HSV-1 inserts were confirmed by spot blot hybridization, and clones with inserts in both orientations were identified by a complementation test (35) .
PCR and RNA PCR. On the basis of Northern analyses, PCR primers were chosen upstream and downstream of the intron within the 2.0-kb LAT (60, 63) . The 95°C , and chilled on ice. To 10 p.l of the first-strand reaction 1 p.M PCR primers and 2.5 U of Taq polymerase were added, and the volume was increased to 100 p.l in lx PCR buffer. Amplifications were performed as for the DNA PCR described above.
DNA sequence determination of cDNA clones in M13 and direct DNA sequence determination of PCR products. DNA sequence determination with single-stranded M13 templates was performed by standard dideoxy-chain termination reactions with Sequenase (USB) and [35S]dATP, with the following modifications for reading through regions of HSV-1 with high GC contents: dITP reagents were used, and 2.5 ,ug of E. coli single-stranded binding protein (USB) was included in the annealing reaction. Following the sequencing reaction, the products were incubated with 100 ,ug of proteinase K per ml at 65°C (twice for 20 min each time) and resolved by urea-polyacrylamide gel electrophoresis. Double-stranded PCR products were sequenced directly without subcloning, as described by Kavaler et al. (24) . To prepare templates for sequencing, PCR products were resolved by electrophoresis in 3% NuSieve GTG (FMC) agarose, ethidium-bromide stained bands were excised, 400 of 50 mM Tris (pH 8.0)-i mM EDTA was added, and the mixture was heated at 65°C for 10 min. After two phenol extractions, sodium acetate was added and the nucleic acids were ethanol precipitated. After centrifugation, the DNA pellets were suspended in TE (10 mM Tris, 1 mM EDTA [pH 7.4]), ethanol precipitated with ammonium acetate, and suspended in TE (""-100 ng/,lI). The PCR primers were also used for DNA sequence determination. To anneal primers to the PCR templates, they were mixed, heated in a boiling water bath for 5 min, and chilled on ice. After addition of 1 x Sequenase buffer and incubation for 5 min at room temperature, DNA sequencing reactions were performed with Sequenase and [32P]dATP by using USB's modifications for manganese buffers. DNA templates were sequenced from both strands, and sequences were analyzed with the DNA Inspector II program (Textco) on a Macintosh SE (Apple).
In vitro translation. The PstI-MluI and HpaI-MluI fragments from the LAT region were subcloned into pGEM4Z, linearized with EcoRI, and in vitro transcribed with T7 polymerase (Promega) by the manufacturer's protocol. The size and integrity of the RNA were confirmed by agarose gel electrophoresis. To translate the RNAs in vitro, they were denatured in a boiling water bath for 3 min and translated with wheat germ extract (Promega) by the manufacturer's Nucleotide sequence accession number. The nucleotide sequence data reported here will appear in the GenBank-EMBO data bases under accession no. M74421.
RESULTS
cDNA cloning of the HSV-1 2.0-kb LAT. To clone the LATs, cDNA libraries were initially constructed with poly(A)+ RNA and an oligo(dT)12_18 primer. These libraries were made before it was known that the LATs were not extensively polyadenylated (49, 59) . Nevertheless, several HSV-1 LAT clones were obtained after screening of more than 106 recombinants. Two of these recombinants (A14 and A20) were used to construct the 2.0-kb LAT continuous sequence (Table 1 and Fig. 2 ). The reason why these clones did not contain the 3' end of the LATs may have been incomplete second-strand synthesis or mispriming during first-strand synthesis. Additional cDNA libraries were constructed with total RNA and primers located within BamHI-B. The contiguous sequence of the cDNA recombinants spanned almost 1.7 kb of the 2.0-kb LAT (Table 1) , starting from nucleotide +23 (59, 64) . The DNA sequence aligned with published sequences for HSV-1 strains F (64), 17+ (41) , and KOS (59) without interruption, although there were minor differences ( Table 2 ). The 3' end of the LATs, which contains ORF1 and ORF2 (Fig. 1D) , is highly conserved between strains F and 17+, and the base changes lead only to one to four amino acid substitutions and a single insertion (Table 2) .
RNA PCR cloning of the intron within the 2.0-kb LAT. Since the 2.0-kb LAT is more abundant than the 1.45-and 1.5-kb LATs ( Fig. 3; 45 (16) .
designed on the basis of data concerning the splice donor and acceptor sites (60, 63) , as well as additional Northern blot mapping ( Fig. 3 and Table 3 ). Although these data are in agreement about the location of the LAT 5' end, there are differences about the position of the splice within the 2.0-kb LAT. The 2.0-kb LAT splice donor site has been reported to lie between nucleotides +21 and + 106 relative to the 5' end of the 2.0-kb LAT by one group (63) and between nucleotides +297 and +314 by another (60) . Northern analysis of strain F with small restriction fragments indicated that probes downstream of an NaeI site at nucleotide +202 hybridize weakly to the smaller LATs ( Fig. 3E and Table 3 ). The putative LAT splice acceptor site has been reported between nucleotides +837 and +1005 (63) and between +1020 and +1058 (60). Northern analysis indicated that the splice acceptor site is near an HpaI site at nucleotide +840 (Compare Fig. 3G and H ).
Since the difference in size between the 2.0-kb LAT and the 1.45-and 1.5-kb LATs is approximately 500 nucleotides, it was expected that this size difference would be reflected in PCR products from RNA templates from latent ganglia, but the smaller RNA PCR product should be amplified more efficiently. These primers (PF and PR2; Table 1 and Fig. 2 ) yielded a PCR product from the appropriate DNA template slightly larger than 1 kb (Fig. 4, lane 9) , and with RNA from mouse trigeminal ganglia latently infected with HSV-1 strain F or 17+, they yielded an RNA PCR product of approximately 500 nucleotides (Fig. 4, lane 1) (41) and relative to the LAT transcription start site (in parentheses; 59, 64) at position 119461 = +1 (LAT). All restriction sites are within BamHI-B (Fig. 1). b Hybridization: ++, strong; +, moderate; +, weak; -, none detectable. The letter designations for the probes correspond to the order of the panels in Fig. 3 .
agreement with the size difference between the 2.0-kb LAT and the 1.45-and 1.5-kb LATs (49) . Several controls were used to confirm that the 500-nucleotide RNA PCR products were not due to DNA contamination, a homologous cellular transcript in control ganglia, or mispriming: (i) the RNA PCR product was not produced when reverse transcriptase was left out of the first-strand reaction, (ii) the RNA PCR product was not produced with RNA from trigeminal ganglia of uninfected control mice, and (iii) it hybridized to a LATspecific probe. The 500-nucleotide LAT RNA PCR products from HSV-1 strains F and 17+ were sequenced directly without subcloning. The sequence of the PCR product aligned with the F and 17+ genomes, with one gap corresponding to 559-and 556-nucleotide introns, respectively (the F DNA sequence is in Fig.  2 ). The 5' junction sequence is (-3)AAG:GCATGT(+5) (Fig. 2  and 5 ), compared with a consensus splice donor junction for protein-encoding genes of (-3)A/CAG:GTA/GAGT(+5) (38) . While the GT following the splice is, with few exceptions (15, 25, 29) , invariant in protein-encoding genes, there is some variability at the neighboring positions (38) . Except for the C at nucleotide +2 after the splice and the allowed, but not preferred, T (underlined) at +4, this splice junction fits with the 5' splice junction consensus. The 3' splice junction (+15) Tlr GTTQCCCTATAG:TGT matches with the consensus splice junction sequence (-15)(T/C)11NC/TAG:NNN(+3). The AG is invariant (38) ; the only variations are the underlined G's at -10 and -12. It should be noted that because the dinucleotide AG is present at both 5' and 3' splice junctions, there is, unavoidably, a two-base ambiguity in the actual position of the splice. The locations of the splice junctions were assigned on the basis of a best fit with consensus junctions.
Effect of 2.0-kb LAT splicing on ORF1 and ORF2 translation. Splicing of the LATs positions the leader sequence within 125 nucleotides of the AUG of ORFi and 195 nucleotides of ORF2 ( Fig. 1D and 2 ; 63, 64). Since there are five AUGs within the 559-nucleotide intron, which specify peptides from 28 to 86 amino acids, it is unlikely, according to Psti-Ml H iva-SPh7l Spohl-SphI NacI-NaeI NaeI-Bs!Ell NeI-HpaI SphI-HoaI H;pal-HpaI ---I (Fig. 2) ; its product with a DNA template is 1,030 bp (lane 9), and that with a latent RNA templatelis 471 bp (lane 1). The other primer pairs, PF2-PR4, PF2-PR5, and PF2-PR7, are located near the LAT 3' termini (Fig. 2) . Although all of the primer pairs amplified DNA templates (lanes 9 to 12), only PF-PR2 and PF2-PR7 amplified PCR products with RNA from the trigeminal ganglia of latently infected mice (lanes 1 and 7) . Lanes: 1, 3, 5, and 7, 1 ,ug of RNA from the trigeminal ganglia of latently infected mice; 2, 4, 6, and 8, 1 ,ug of RNA from the trigeminal ganglia of uninfected controls; 9 to 12, 1 ng of BamHI-E. The marker is a 123-bp ladder (Bethesda Research Laboratories).
the scanning model of Kozak (26, 27) , that many ribosomes would translate either ORFi or ORF2 from the 2.0-kb LAT.
The sequence surrounding the AUG for ORFi (AGGAUGC) differs from the Kozak consensus A/GNNAUGG, but the sequence surrounding the AUG for ORF2 (AACAUGG) does fit the consensus. Thus, it is theoretically possible that the LAT is polycistronic and that ORF1 and ORF2 are expressed from the same transcript. Precedent for this possibility is that a single HSV-1 thymidine kinase mRNA specifies at least three polypeptides by initiating protein synthesis at three AUGs and that the first two AUGs differ from the Kozak consensus (19) . Alternatively, only ORF2 may be expressed or there may be no 2.0-kb LAT-encoded protein.
To examine the hypotheses that the LAT intron interferes with translation and that the LAT encodes more than one protein, the LAT region (PstI-MIuI; Fig. 1C ) and a LAT subfragment located downstream of the LAT intron (HpaIMIuI) were cloned into a plasmid vector (pGEM4Z; Promega) for in vitro transcription-translation. T7 
. DNA sequence determination of the LAT splice junction. The splice junction was amplified by RNA PCR with primers spanning the intron and RNA isolated from trigeminal ganglia of mice latently infected with HSV-1 strain 17+. The sequence presented is from the reverse strand. The asterisk and the underlined base pair indicate the splice junction. The splice junction utilized in HSV-1 strain F was identical (data not shown). The splice junction sequence is also conserved in HSV-1 strain KOS (59). ase transcribed RNA from both constructs of the appropriate sizes, i.e., 2.8 and 1.2 kb, respectively (data not shown). However, neither RNA was successfully translated by rabbit reticulocyte lysates, regardless of whether or not the RNAs were capped or heat denatured at temperatures of up to 95°C to minimize secondary structure (data not shown). When wheat germ extracts were used and the RNA was heat denatured at 95°C, the HpaI-MluI RNA was translated to yield polypeptides of approximately 28, 24, and 12 kDa, as well as some minor species (Fig. 6) . No polypeptides were produced when the in vitro-transcribed RNA was heated to 65°C prior to translation (data not shown). The predicted size of ORFi is 30 kb, but since the HpaI-MluI construct lacks the first 17 amino acids of ORF1, the 28-kDa polypeptide is approximately the correct size. Both the 28-and 24-kDa polypeptides could be the result of initiation at codons other than AUG (26) . The 12-kDa polypeptide corresponds to the predicted size of the ORF2 product (63, 64) . The construct containing the entire 2.0-kb LAT did not translate well under any of the conditions tested; faint bands were present at about 30, 24, and 12 kDa (Fig. 6) . In this construct, all of ORFi is present so that the polypeptide is slightly larger than that generated from the HpaI-MluI construct. The other polypeptides produced from the PstI-MluI construct were similar in size to those of the HpaI-MluI construct. These results suggest that the LATs can potentially encode more than one polypeptide and that the LAT intron can inhibit efficient translation of ORFi and ORF2.
Cloning of the 3' termini of the LATs by RNA PCR. The 3' ends of all three LATs map to a region between a BstEII site and an Sfil site ( Fig. 1 and Table 3 ). In a P-galactosidase plasmid construct, consensus splice signals near the 5' and 3' 2.0-kb LAT termini were utilized in transfected cells (16) . On the basis of this result, it was hypothesized that these splice signals may also be recognized in vivo during latent HSV-1 infection and that the 2.0-kb LAT may be an intron spliced from a large primary transcript. RNA PCR was also used to examine the 3' termini of the LATs, because cDNA clones of this region were not obtained. Several primers were synthesized both upstream and downstream of this putative 3' splice acceptor site ( Fig. 2; 16) . The primer pair PF2-PR4 was designed to amplify a PCR product that corresponds exactly to the putative 3' LAT splice junction and terminus (Fig. 2) . Primer PR5 is located just beyond this splice signal, and PR6 is located downstream of the MluI site (Fig. 1) . With DNA templates, the primer pairs PF2-PR4, PF2-PR5 (Fig. 4) , and PF2-PR6 (data not shown) produced PCR products of the expected sizes, i.e., 448, 470, and 774 bp, respectively. However, none of these primer sets amplified RNA PCR products with RNA from the trigeminal ganglia of latently infected mice (Fig. 4, lanes 3 and 5) . Also, an SfiI-MluI probe (Fig. 1C) , which contains PR4 and PR5, did not hybridize to the 3' end of the LATs (Table 3) . A primer, PR7, just upstream of the SfiI site, in combination PF2 yielded a PCR product of 370 bp from a DNA template (Fig.  4, lane 12) and an RNA PCR product of the same size with RNA from the trigeminal ganglia of latently infected mice (Fig. 4, lane 7) . The identity of this PCR product was confirmed by DNA sequence determination (Fig. 2) . This positions the 3' end of the LATs between PR7 and PR4, which indicates that the actual size of the body of the 2.0-kb LAT is greater than 1,876 nucleotides but less than 1,956 nucleotides. These data indicate that in latently infected mouse trigeminal ganglia, the 3' terminus of the 2.0-kb LAT is upstream of the consensus splice acceptor site utilized in cells transfected with a ,3-galactosidase-HSV-1 LAT plasmid (16) .
DISCUSSION
The LAT transcription unit. Although the HSV-1 LAT transcription unit has been studied in detail, several issues have not been resolved. While three LATs have been detected on Northern blots, the LATs lie within a larger region that is positive by in situ hybridization during latency (10, 11, 36, 37, 54) . This hybridization may represent one or more additional LATs, including a large primary transcript (8.5 kb) which is rapidly processed to form the 2.0-, 1.5-, and 1.45-kb LATs, as well as some putative large transcripts (-6.5 kb; 12, 13, 68 LAT splice for HSV-1 strains F and 17+ ( Fig. 2 and Fig. 4 , lanes 7 and 12), although it has been proposed that the LATs contain a small 3' intron (63 Effect of 2.0-kb LAT splicing on ORF1 and ORF2 translation. There are two ORFs at the 3' end of the 2-kb LAT ( Fig.  1 and 2; 63, 64 ). Another ORF has been proposed in strain KOS (59) , within the intron removed from the 2.0-kb LAT, but this ORF is not present in strain 17+ or F (64) . There are no data that indicate that any LAT-encoded proteins are present in vivo, so any hypotheses about their existence or function is speculative. Removal of the LAT intron positions the 276-nucleotide leader sequence 125 and 195 nucleotides from the AUGs of ORF1 and ORF2, respectively ( Fig. 1D  and 2 ; 63, 64), which might facilitate translation of these polypeptides. The LAT intron contains five AUGs, as well as significant secondary structure that inhibits in vitro translation of ORF1 and ORF2 (Fig. 6 ) and may also affect LAT translation during latency or reactivation. In an in vitro HSV-1 latency model, there is a report of an 80-kDa protein encoded from the region of ORF2 (14) . Although ORF2 encodes a 30-kDa protein ( Fig. 6; 64) , it was suggested that a larger ORF might be created by RNA splicing (14) . The data in this report indicate that 2.0-kb LAT splicing does not generate new ORFs in vivo.
There are some interesting similarities between the putative LAT polypeptides encoded by ORF1 and ORF2 and Epstein-Barr virus nuclear antigens (EBNAs) that are expressed during latent infection (47 (4, 20, 21, 23, 30, 53) .
Structure of the 2.0-kb LAT. It has been hypothesized that the 2.0-kb LAT is a stable intron (13, 16) and that the functional portion of the LAT gene lies in the regions of minor hybridization upstream and downstream of the 2.0-kb LAT (10, 11, 36, 37, 54) . The DNA sequence surrounding the 2.0-kb LAT transcription start site is (-15)ACGCCGCGTT TCCA:GGTAGGT(+7) (59, 64) . If the transcription start site is shifted one nucleotide to the right, then the sequence CAG:GTA£GT fits with a consensus 5' splice donor signal, except for the underlined G at +4, which is used infrequently (38) (25, 40) . Insertion of P-galactosidase into the 2.0-kb LAT demonstrates that ORFs within the 2.0-kb LAT can be expressed during latent infection (21) . However, the data in this report do not support the hypothesis that the 3' end of the 2.0-kb LAT corresponds to the above-described splice junction, because the 3' end of the LATs is upstream of the proposed splice acceptor and is located between PR7 and PR4 ( Fig. 2 and 4 ). This implies that the size of the 2.0-kb LAT is actually between 1,876 and 1,956 nucleotides.
If the LATs are not introns, then they may have a short leader sequence or may be transcripts that initiate almost 700 nucleotides from their promoter. There is no direct evidence that the LATs contain a 5' leader sequence. Hybridization of Northern blots with probes between the promoter and the 5' end of the 2.0-kb LAT was negative ( Fig. 3B ; 45, 49, 59, 63) . Since the region spanned by the cDNA clones and RNA PCR products is about 1,900 nucleotides, any putative leader sequence would be short and might not be detected on Northern blots. An example of a short 5' sequence is the tripartite leader of the adenovirus major late transcript (1, 66) .
There are several genes in which the nearest TATA box and CAAT box are several hundred nucleotides upstream of the transcription start site and the 5' sequences are GC rich. These genes include those for hypoxanthine phosphoribosyltransferase (57), 3-hydroxy-3-methylglutaryl coenzyme A reductase (43) , adenosine deaminase (65) , dihydrofolate reductase (5) , and 3-phosphoglycerate kinase (48) . Genes lacking TATA boxes near transcription start sites can initiate at multiple positions (3, 33) . By analogy, the transcription observed during latent HSV-1 infection may be from a single promoter by initiation at more than one site. Transcription from an upstream site(s) would account for the minor in situ hybridization (10, 11, 36, 37, 54) , and transcription from a downstream site would account for the LATs detectable by Northern blotting (45, 49, 56) . Further support for a transcription start at the 5' end of the LATs is the neuronspecific regulatory element CCAGG (33), just 5' of the 2.0-kb LAT. Since the next closest CCAGG is over 2 kb upstream of the LAT promoter, this may account for preferential usage of a 2.0-kb LAT transcription start site rather than initiation close to the LAT promoter. In tissue culture infection, there is evidence for partial capping of the 2.0-kb VOL. 65, 1991 LAT (12) , which would be consistent with either a short leader sequence or downstream transcription initiation sites.
Implications for LAT function. HSV-1 deletion mutants lacking the LAT promoter exhibit impaired reactivation from explanted mouse trigeminal ganglia (30, 54) and in the rabbit eye model (58a). An HSV-1 x HSV-2 recombinant with a deletion encompassing the LAT promoter also reactivated inefficiently in the rabbit eye model (20) . In contrast, two HSV-1 LAT mutants that contain an intact LAT promoter reactivate normally in explanted ganglia. (i) RH142 contains the f-galactosidase gene inserted at nucleotide +136 relative to the 5' end of the 2.0-kb LAT and a deletion from + 136 to +509 which removes the splice donor site and a portion of the 2.0-kb LAT intron (21 
